GLOBUS MEDICAL INC GMED
i
Market dataready · fetched 2026-11-11T15:39:28.379Z
Delta surfaceAlpaca · derived absolute-delta buckets · 2026-11-20
Calculation methodologyOptions historyIV: ThetaData historical Greeks, equal-weight mean of call/put 50-delta IV across the next four listed Friday-cycle expirations, including holiday shifts verified against ThetaData’s market calendar. Missing inputs leave gaps. Skew: equal-weight mean of put minus call IV across those four expirations. IV-implied move history: mean of each expiration’s average call/put IV multiplied by the square root of remaining calendar days divided by 365.25; percentage of spot, not a quoted straddle premium.
History dataPriceAlpaca · sip · 2026-11-11T15:39:08.715434538Z
FundamentalsSEC EDGAR · ready · as of 2026-09-30 · fetched 2026-11-11T15:39:27.743427+00:00
GLOBUS MEDICAL INC options
Table
| Delta | Calls | Puts | ||||
|---|---|---|---|---|---|---|
| Pseudo strike | IV | B/E move | Pseudo strike | IV | B/E move | |
| 20Δ | 79.55 | 43.1% | 7.2% | 70.60 | 45.7% | 6.5% |
| 25Δ | 78.38 | 39.9% | 5.8% | 71.27 | 49.0% | 6.0% |
| 30Δ | 77.36 | 38.4% | 4.7% | 71.93 | 52.3% | 5.5% |
| 35Δ | 76.78 | 42.3% | 4.4% | 72.62 | 54.4% | 4.9% |
| 40Δ | 76.21 | 46.1% | 4.2% | 73.40 | 50.1% | 4.1% |
| 45Δ | 75.63 | 50.0% | 3.9% | 74.18 | 45.7% | 3.3% |
| 50Δ | 75.06 | 53.9% | 3.7% | 74.96 | 41.4% | 2.4% |
| 55Δ | 74.35 | 52.4% | 3.1% | 75.48 | 39.5% | 2.0% |
| 60Δ | 73.62 | 50.4% | 2.6% | 76.00 | 37.7% | 1.7% |
| 65Δ | 72.90 | 48.4% | 2.0% | 76.51 | 36.0% | 1.3% |
| 70Δ | 72.09 | 47.5% | 1.6% | 77.02 | 34.2% | 1.0% |
| 75Δ | 71.20 | 48.1% | 1.3% | 77.86 | 33.6% | 0.6% |
| 80Δ | 70.30 | 48.7% | 1.0% | 84.11 | 51.3% | 0.5% |
20Δ
- Pseudo strike
- 79.55
- IV
- 43.1%
- B/E move
- 7.2%
- Pseudo strike
- 70.60
- IV
- 45.7%
- B/E move
- 6.5%
25Δ
- Pseudo strike
- 78.38
- IV
- 39.9%
- B/E move
- 5.8%
- Pseudo strike
- 71.27
- IV
- 49.0%
- B/E move
- 6.0%
30Δ
- Pseudo strike
- 77.36
- IV
- 38.4%
- B/E move
- 4.7%
- Pseudo strike
- 71.93
- IV
- 52.3%
- B/E move
- 5.5%
35Δ
- Pseudo strike
- 76.78
- IV
- 42.3%
- B/E move
- 4.4%
- Pseudo strike
- 72.62
- IV
- 54.4%
- B/E move
- 4.9%
40Δ
- Pseudo strike
- 76.21
- IV
- 46.1%
- B/E move
- 4.2%
- Pseudo strike
- 73.40
- IV
- 50.1%
- B/E move
- 4.1%
45Δ
- Pseudo strike
- 75.63
- IV
- 50.0%
- B/E move
- 3.9%
- Pseudo strike
- 74.18
- IV
- 45.7%
- B/E move
- 3.3%
50Δ
- Pseudo strike
- 75.06
- IV
- 53.9%
- B/E move
- 3.7%
- Pseudo strike
- 74.96
- IV
- 41.4%
- B/E move
- 2.4%
55Δ
- Pseudo strike
- 74.35
- IV
- 52.4%
- B/E move
- 3.1%
- Pseudo strike
- 75.48
- IV
- 39.5%
- B/E move
- 2.0%
60Δ
- Pseudo strike
- 73.62
- IV
- 50.4%
- B/E move
- 2.6%
- Pseudo strike
- 76.00
- IV
- 37.7%
- B/E move
- 1.7%
65Δ
- Pseudo strike
- 72.90
- IV
- 48.4%
- B/E move
- 2.0%
- Pseudo strike
- 76.51
- IV
- 36.0%
- B/E move
- 1.3%
70Δ
- Pseudo strike
- 72.09
- IV
- 47.5%
- B/E move
- 1.6%
- Pseudo strike
- 77.02
- IV
- 34.2%
- B/E move
- 1.0%
75Δ
- Pseudo strike
- 71.20
- IV
- 48.1%
- B/E move
- 1.3%
- Pseudo strike
- 77.86
- IV
- 33.6%
- B/E move
- 0.6%
80Δ
- Pseudo strike
- 70.30
- IV
- 48.7%
- B/E move
- 1.0%
- Pseudo strike
- 84.11
- IV
- 51.3%
- B/E move
- 0.5%
Options history
Table
| Date | IV (%) |
|---|---|
| 35.89% | |
| 34.66% | |
| 36.76% | |
| 35.87% | |
| 37.89% | |
| 34.46% | |
| 33.92% | |
| 33.53% | |
| 34.43% | |
| 34.41% | |
| 34.18% | |
| 35.23% | |
| 34.96% | |
| 35.04% | |
| 34.01% | |
| 33.98% | |
| 35.51% | |
| 35.88% | |
| 35.53% | |
| 34.61% | |
| 36.36% | |
| 37.96% | |
| 41.78% | |
| 37.55% | |
| 36.24% | |
| 36.14% | |
| 36.06% | |
| 35.99% | |
| 36.31% | |
| 38.32% | |
| 37.67% | |
| 36.56% | |
| 36.98% | |
| 34.54% | |
| 36.33% | |
| 37.63% | |
| 39.57% | |
| 39.56% | |
| 35.35% | |
| 41.20% | |
| 41.61% | |
| 44.19% | |
| 39.60% | |
| 39.80% | |
| 40.03% | |
| 39.52% | |
| 41.38% | |
| 41.99% | |
| 41.48% | |
| 42.52% | |
| 40.25% | |
| 41.51% | |
| 45.87% |
Medical Devices
HAE
Haemonetics Corporation, a healthcare company, offers medical products and solutions. The company is headquartered in Boston, Massachusetts.
More →HYPR
Hyperfine Inc. is a pioneering force in medical technology, renowned for developing the world’s first FDA-cleared portable MRI system, which significantly enhances diagnostic…
More →IART
Integra LifeSciences Holdings Corporation develops, manufactures, and markets surgical implants and medical instruments for use in neurosurgery, limb reconstruction, orthopedics,…
More →INFU
InfuSystem Holdings, Inc., provides infusion pumps and related products and services in the United States and Canada. The company is headquartered in Rochester Hills, Michigan.
More →INGN
Description unavailable
More →INMD
InMode Ltd. designs, develops, manufactures and markets minimally invasive aesthetic medical products based on its proprietary RF-assisted lipolysis and deep subdermal fractional…
More →